Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Waiting Time for Second Kidney Transplantation and Mortality

A. Kainz, M. Kammer, R. Reindl-Schwaighofer, S. Strohmaier, V. Petr, O. Viklicky, D. Abramowicz, M. Naik, G. Mayer, R. Oberbauer

. 2022 ; 17 (1) : 90-97. [pub] 20211229

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011438
E-zdroje Online Plný text

NLK Free Medical Journals od 2006 do Před 1 rokem
PubMed Central od 2008 do Před 1 rokem
Europe PubMed Central od 2008 do Před 1 rokem
Open Access Digital Library od 2006-01-01

BACKGROUND AND OBJECTIVES: The median kidney transplant half-life is 10-15 years. Because of the scarcity of donor organs and immunologic sensitization of candidates for retransplantation, there is a need for quantitative information on if and when a second transplantation is no longer associated with a lower risk of mortality compared with waitlisted patients treated by dialysis. Therefore, we investigated the association of time on waiting list with patient survival in patients who received a second transplantation versus remaining on the waiting list. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective study using target trial emulation, we analyzed data of 2346 patients from the Austrian Dialysis and Transplant Registry and Eurotransplant with a failed first graft, aged over 18 years, and waitlisted for a second kidney transplantation in Austria during the years 1980-2019. The differences in restricted mean survival time and hazard ratios for all-cause mortality comparing the treatment strategies "retransplant" versus "remain waitlisted with maintenance dialysis" are reported for different waiting times after first graft loss. RESULTS: Second kidney transplantation showed a longer restricted mean survival time at 10 years of follow-up compared with remaining on the waiting list (5.8 life months gained; 95% confidence interval, 0.9 to 11.1). This survival difference was diminished in patients with longer waiting time after loss of the first allograft; restricted mean survival time differences at 10 years were 8.0 (95% confidence interval, 1.9 to 14.0) and 0.1 life months gained (95% confidence interval, -14.3 to 15.2) for patients with waiting time for retransplantation of <1 and 8 years, respectively. CONCLUSIONS: Second kidney transplant is associated with patient survival compared with remaining waitlisted and treatment by dialysis, but the survival difference diminishes with longer waiting time.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011438
003      
CZ-PrNML
005      
20220506130619.0
007      
ta
008      
220425s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.2215/CJN.07620621 $2 doi
035    __
$a (PubMed)34965955
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kainz, Alexander $u Department of Nephrology, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/000000018888440X
245    10
$a Waiting Time for Second Kidney Transplantation and Mortality / $c A. Kainz, M. Kammer, R. Reindl-Schwaighofer, S. Strohmaier, V. Petr, O. Viklicky, D. Abramowicz, M. Naik, G. Mayer, R. Oberbauer
520    9_
$a BACKGROUND AND OBJECTIVES: The median kidney transplant half-life is 10-15 years. Because of the scarcity of donor organs and immunologic sensitization of candidates for retransplantation, there is a need for quantitative information on if and when a second transplantation is no longer associated with a lower risk of mortality compared with waitlisted patients treated by dialysis. Therefore, we investigated the association of time on waiting list with patient survival in patients who received a second transplantation versus remaining on the waiting list. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective study using target trial emulation, we analyzed data of 2346 patients from the Austrian Dialysis and Transplant Registry and Eurotransplant with a failed first graft, aged over 18 years, and waitlisted for a second kidney transplantation in Austria during the years 1980-2019. The differences in restricted mean survival time and hazard ratios for all-cause mortality comparing the treatment strategies "retransplant" versus "remain waitlisted with maintenance dialysis" are reported for different waiting times after first graft loss. RESULTS: Second kidney transplantation showed a longer restricted mean survival time at 10 years of follow-up compared with remaining on the waiting list (5.8 life months gained; 95% confidence interval, 0.9 to 11.1). This survival difference was diminished in patients with longer waiting time after loss of the first allograft; restricted mean survival time differences at 10 years were 8.0 (95% confidence interval, 1.9 to 14.0) and 0.1 life months gained (95% confidence interval, -14.3 to 15.2) for patients with waiting time for retransplantation of <1 and 8 years, respectively. CONCLUSIONS: Second kidney transplant is associated with patient survival compared with remaining waitlisted and treatment by dialysis, but the survival difference diminishes with longer waiting time.
650    _2
$a dospělí $7 D000328
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a chronické selhání ledvin $x mortalita $x chirurgie $7 D007676
650    _2
$a transplantace ledvin $x statistika a číselné údaje $7 D016030
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a opakovaná terapie $x statistika a číselné údaje $7 D019233
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a časové faktory $7 D013997
650    12
$a seznamy čekatelů $7 D014850
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kammer, Michael $u Department of Nephrology, Medical University of Vienna, Vienna, Austria $u Institute of Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria
700    1_
$a Reindl-Schwaighofer, Roman $u Department of Nephrology, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000244196282
700    1_
$a Strohmaier, Susanne $u Department of Epidemiology, Medical University of Vienna, Vienna, Austria
700    1_
$a Petr, Vojtěch $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Viklicky, Ondrej $u Department of Nephrology, Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Abramowicz, Daniel $u Department of Nephrology, Antwerp University Hospital, Antwerp, Belgium $1 https://orcid.org/0000000265569199
700    1_
$a Naik, Marcel $u Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin, Berlin, Germany $u Berlin Institute of Health, Berlin, Germany
700    1_
$a Mayer, Gert $u Department of Internal Medicine IV-Nephrology and Hypertension, Medical University of Innsbruck, Innsbruck, Austria $u Austrian Dialysis and Transplant Registry, Innsbruck, Austria
700    1_
$a Oberbauer, Rainer $u Department of Nephrology, Medical University of Vienna, Vienna, Austria rainer.oberbauer@meduniwien.ac.at
773    0_
$w MED00156165 $t Clinical journal of the American Society of Nephrology : CJASN $x 1555-905X $g Roč. 17, č. 1 (2022), s. 90-97
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34965955 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130611 $b ABA008
999    __
$a ok $b bmc $g 1789169 $s 1162636
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 17 $c 1 $d 90-97 $e 20211229 $i 1555-905X $m Clinical journal of the American Society of Nephrology $n Clin J Am Soc Nephrol $x MED00156165
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...